Novozymes Sweden AB

ABIn liquidation

Org 5566270830Manufacture of pharmaceutical preparations · NACE 2120Est. 20021 employees

Overview Financials People & ownership Related companies

Novozymes Sweden AB is a Swedish AB, operating in the Tillverkning av läkemedel sector. Incorporated in 2002, the company has 1 employees and reported revenue of SEK 1,7M in its latest annual filing.

Revenue 2022

SEK 1,7M

-38% vs 2021

EBITDA margin

6.4%

+954% vs 2021

Equity ratio

91.4%

Financial strength

Net profit 2022

SEK 130K

+548% vs 2021

EBITDA — year on year

SEK millions

Key figures

Annual report 2022

Revenue	SEK 1,7M	-38%
EBITDA	SEK 111K	+954%
Net profit	SEK 130K	+548%
Total assets	SEK 5,7M	+5%
Equity	SEK 5,2M	+3%
Employees	1	—

Contact

Address

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Novozymes Sweden AB?

Novozymes Sweden AB is registered with Bolagsverket / SCB under Org 5566270830.

What is the revenue of Novozymes Sweden AB?

Novozymes Sweden AB reported revenue of SEK 1,7M in 2022.

How many employees does Novozymes Sweden AB have?

Novozymes Sweden AB employs 1 people as of the latest annual report.

Who is the CEO of Novozymes Sweden AB?

Torbjörn Mikael Åberg is Chief Auditor of Novozymes Sweden AB, in role since 2020.

Novozymes Sweden AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Novozymes Sweden AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Novozymes Sweden AB